In less than 36 hours between the evening of January 12 and the morning of January 14, three local life sciences companies, Tune Therapeutics, Truveta, and Umoja Biopharma raised a combined total of $595M. The news seemed to signal a shifting tide in the biotech industry, which in recent years has been hit by layoffs and declining venture funding. But multiple life sciences leaders say it’s not so simple, and the big funding rounds to start the year aren’t necessarily a preview of what’s to come in the months ahead.
These Seattle-Area Life Sciences Startups Raised $595M in 36 Hours. Here’s What’s Going On.
Share: